Yiannis Ioannou

Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Ernest Choy, David Isenberg, Toby Garrood et al. · Arthritis & Rheumatism · 2002 · 535 citations

Life Sciences, Immunology, Pharmacotherapy +15

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

Shabina Sultan, Yiannis Ioannou, K. Moss et al. · Lara D. Veeken · 2002 · 272 citations

Medicine, Internal Medicine, Autoimmunity +15

Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort

L. Watson, Valentina Leone, Clarissa Pilkington et al. · Arthritis & Rheumatism · 2012 · 233 citations · Full text

Medicine, Pediatrics, Pediatric Epidemiology +12

Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Guillermo Barturen, Sepideh Babaei, Francesc Català‐Moll et al. · Arthritis & Rheumatology · 2020 · 188 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

Perrine Soret, Christelle Le Dantec, Emiko Desvaux et al. · Nature Communications · 2021 · 167 citations · Full text

Medicine, Immunology, Molecular Medicine +17